CHAMPIONS ONCOLOGY, INC.
Nasdaq: CSBRBiological Products, (No Diagnostic Substances) · Entity-resolved by Clous
CIK0000771856
TickerCSBR
ExchangeNasdaq
SIC2836
StateDE
FY end04-30
Illustrative profile — live data lights up when a server API key is configured.
Key financials
RevenueFY2025-04-30
$56.94M
+13.5% YoY
Net IncomeFY2025-04-30
$4.7M
+164.6% YoY
Total AssetsFY2025-04-30
$32.34M
+23.8% YoY
EquityFY2025-04-30
$3.77M
+298.2% YoY
Shares OutstandingFY2025-04-30
13.78M
—
Operating Cash FlowFY2025-04-30
$7.39M
+220.4% YoY
Market
Market
CSBRClose price
$6.34
Market cap
$88.04M
delayed EOD · as of 2026-06-18
Short interest & fails
Cost to borrow0.46%950K shares availablegeneral collateral
Fails-to-deliver
SEC CNS fails · semi-monthly112
shares failed · 2026-05-11
2026-05-11112 sh$6.02
2026-04-133.28K sh$5.69
2026-04-103.51K sh$5.75
2026-03-31325 sh$5.84
2026-03-27109 sh$5.78
Short volume (FINRA Reg SHO) · fails-to-deliver (SEC) · borrow fee (broker securities-lending feed) — via the Clous API.
| Concept | FY2022-04-30 | FY2023-04-30 | FY2024-04-30 | FY2025-04-30 | YoY | % rev |
|---|---|---|---|---|---|---|
| Revenue | $49.11M | $53.87M | $50.16M | $56.94M | +13.5% | 100% |
| Net Income | $548K | -$5.34M | -$7.28M | $4.7M | +164.6% | 8% |
| Total Assets | $35.38M | $34.31M | $26.13M | $32.34M | +23.8% | 57% |
| Equity | $9.1M | $4.64M | -$1.9M | $3.77M | +298.2% | 7% |
| Operating Cash Flow | $6.5M | $3.97M | -$6.14M | $7.39M | +220.4% | 13% |
| Shares Outstanding | — | — | — | 13.78M | — | — |
Get this entity — and 970.89K+ others — programmatically.
One clean JSON shape, resolved IDs, MCP-native. Query the same data behind this page.
GET /v1/entities?cik=0000771856